About Ultraceuticals & Fortem Biosciences
Welcome to Ultraceuticals, a visionary endeavor by Fortem Biosciences Pvt. Ltd., where innovation meets healthcare. Nestled in the tech hub of Bangalore, India, we are an interdisciplinary neo-biotech enterprise dedicated to transforming the preclinical landscape of drug discovery, repurposing, and solid-state formulation.
Pioneering the Future of Healthcare Through Computational Biology
Our mission is to bring affordable, high-efficacy medicines to global markets by reducing development timelines and costs while maintaining the highest standards of accuracy. We bridge the gap between advanced deep learning and practical healthcare solutions, accelerating the development of effective treatments for chronic, metabolic, and neurodegenerative diseases.
Global Leadership in AI-Driven Drug Discovery & Formulation
We envision a future where our AI-first pharmaceutical operating system becomes a cornerstone in the development of new, life-saving medications worldwide. Creating a more sustainable, ethical, and accessible approach to drug development that promotes global well-being, inclusivity, and scientific excellence.
Four Years of Scientific Maturation
From founding algorithms to full-stack pharmaceutical intelligence. Fortem Biosciences has systematically de-risked every phase of the drug discovery, repurposing, and formulation lifecycle.
Founding & Heterogeneous Graph Architecture
Fortem Biosciences established Ultraceuticals in Bangalore with an algorithmic mandate. Initial construction of the human interactome heterogeneous knowledge graph and computational chemistry algorithms.
DiscoveraAI & DynaDock Molecular Dynamics
Expanded into generative chemistry for small molecules and biologics. Integrated microsecond-scale GPU molecular dynamics, DTPred target prediction, and FoldPredict 3D structural modeling.
ReviveAI (SCALEX) Enterprise Repurposing
Deployed the clinical-grade drug repurposing platform. Node-level contrastive GNNs with modality dropout defense, identifying high-confidence repositioning vectors for neurodegenerative diseases.
Dossier360 Autonomous Regulatory Swarm
Engineered multi-agent legal and scientific due-diligence intelligence. Ingestion of USPTO/WIPO claim graphs, Hatch-Waxman patent thicket triaging, and bioequivalence risk automation.
Enformis: The Solid-State Revolution
Our most recent breakthrough: Fine-tuned ChemBERTa predictive formulation AI. Predicts thermal degradation onset (Tonset ±3.8°C), crystal habits, and excipient synergy before wet-lab compounding.
Our Cultural & Engineering Principles
The foundational standards that define Fortem Biosciences & Ultraceuticals.
Quality is Our Habit
“We have made quality our habit. It’s not something that we just strive for - we live by this principle every day.” Every predictive algorithm, molecular simulation, and formulation kinetic model is rigorously benchmarked against gold-standard wet-lab assays.
Engineering at Computational Scale
Bridging novel drug design and generic medicines with cutting-edge AI - delivering the accuracy, scale, and scientific trust global pharma demands across de novo discovery, repurposing, and formulation.
Preemptive Formulation Intelligence
Solving the 90% formulation failure rate before wet-lab compounding. Enformis models thermal onset degradation, crystal habits, and excipient synergy at the earliest in silico stages.
Zero Trust & HIPAA Air-Gapping
Client-nominated biological targets, proprietary chemical matter, and genomic data are protected under strict Zero Trust Architecture with 100% offline air-gapping and mutual NDA terms.
Driven by World-Class Scientists, AI Researchers & Clinicians
Meet the founders, deep learning architects, organic medicinal chemists, and medical advisors turning biopharmaceutical possibilities into verified clinical leads.
Executive Leadership & Founders
Core Technology & AI Architecture Team
Core Scientific & Chemical Discovery Team
Dr. Nirupma Jadon (Singh)
PhD in Chemistry. Extensive expertise in microwave-induced organic synthesis, active chemical compound formulation, excipient stability, and antimicrobial evaluation.
Amardeep Singh
M.Sc. Eng. in Chemical Engineering & Applied Chemistry. Bridging molecular dynamics forcefields with deep learning surrogate models.
Dr. Madhuri Pola
Academic prowess in structure-based drug design, multi-omics bioinformatics, biotechnology, and high-yield bioprocess optimization.
Scientific & Clinical Advisory Board
Dr. Soumya Ghosh
Advising on institutional, national, and international research translation grants (DBT, BIRAC, and global health foundations).
Dr. Ravindra Kumar
Assistant Professor at National Institute of Technology (NIT) Calicut. Guiding computational biophysics and macromolecular modeling.
Dr. Megha Rao
Guiding clinical progression protocols, patient safety endpoints, and therapeutic interchangeability across candidate drug classes.
Dr. Archa Prasad
Shaping clinical trial protocols, GCP compliance, and international regulatory dossier submissions to FDA and EMA benchmarks.
Dr. KV Ganapathy
Advising on patient-centric due diligence, formulation bioavailability, and bioequivalence validation pathways.
Ready to Accelerate Your Preclinical Discovery?
Whether you are an institutional pharma co-developer, biotech venture partner, or academic investigator - our team is ready to accelerate your pipeline.